Abstract
After reacting with hydrogen peroxide (H2O2), sickle-cell hemoglobin (HbS, βE6V) remains longer in a highly oxidizing ferryl form (HbFe4+=O) and induces irreversible oxidation of “hot-spot” amino acids, including βCys-93. To control the damaging ferryl heme, here we constructed three HbS variants. The first contained a redox-active Tyr in β subunits (F41Y), a substitution present in Hb Mequon; the second contained the Asp (K82D) found in the β cleft of Hb Providence; and the third had both of these β substitutions. Both the single Tyr-41 and Asp-82 constructs lowered the oxygen affinity of HbS but had little or no effects on autoxidation or heme loss kinetics. In the presence of H2O2, both rHbS βF41Y and βF41Y/K82D enhanced ferryl Hb reduction by providing a pathway for electrons to reduce the heme via the Tyr-41 side chain. MS analysis of βCys-93 revealed moderate inhibition of thiol oxidation in the HbS single F41Y variant and dramatic 3- to 8-fold inhibition of cysteic acid formation in rHbS βK82D and βF41Y/K82D, respectively. Under hypoxia, βK82D and βF41Y/K82D HbS substitutions increased the delay time by ∼250 and 600 s before the onset of polymerization compared with the rHbS control and rHbS βF41Y, respectively. Moreover, at 60 °C, rHbS βK82D exhibited superior structural stability. Asp-82 also enhanced the function of Tyr as a redox-active amino acid in the rHbS βF41Y/K82D variant. We conclude that the βK82D and βF41Y substitutions add significant resistance to oxidative stress and anti-sickling properties to HbS and therefore could be potential genome-editing targets.
Highlights
After reacting with hydrogen peroxide (H2O2), sickle-cell hemoglobin (HbS, E6V) remains longer in a highly oxidizing ferryl form (HbFe4؉؍O) and induces irreversible oxidation of “hot-spot” amino acids, including Cys-93
In the presence of H2O2, both recombinant HbS (rHbS) F41Y and F41Y/K82D enhanced ferryl Hb reduction by providing a pathway for electrons to reduce the heme via the Tyr-41 side chain
Polymerization of intraerythrocytic deoxy-HbS is the primary molecular event that leads to hemolytic anemia, evidence is emerging that oxidation side reactions of Hb within SS RBCs, RBC-derived microparticles (MPs), and the released free Hb contribute to the complex pathophysiology of the disease [4]
Summary
After reacting with hydrogen peroxide (H2O2), sickle-cell hemoglobin (HbS, E6V) remains longer in a highly oxidizing ferryl form (HbFe4؉؍O) and induces irreversible oxidation of “hot-spot” amino acids, including Cys-93. Our group has previously shown that HbProv (K82D) is more resistant to damage by H2O2 than native HbA because of its ability to better quench the ferryl radicals through an efficient ferric/ferryl pseudoperoxidase cycle [13] We subsequently engineered this unusual oxidative stability into a genetically cross-linked human tetramer as a potential oxygen therapeutic [14]. The HbProv mutation conferred more resistance to degradation by H2O2 by inhibiting oxidation of the 93 cysteine side chain To test whether this property could mitigate sickling and degradation of HbS, we constructed an rHb containing the double mutant, E6V/K82D. Our data show that substitution of Phe at position 41 with a redox-active Tyr in the  subunit provides an effective electron pathway to reduce the levels of ferryl heme, in the presence of ascorbate as a physiologically relevant, mild reducing agent. Development and gene therapy interventions, if reversal of the V6E mutation is difficult
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.